首页> 美国卫生研究院文献>Heliyon >Chemical profiles pharmacological properties and in silico studies provide new insights on Cycas pectinata
【2h】

Chemical profiles pharmacological properties and in silico studies provide new insights on Cycas pectinata

机译:化学概况药理特性和计算机模拟研究为苏铁属提供了新见解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current study aimed to qualitatively and quantitatively determine the phytochemical components of methanol extract (MECP), along with its antioxidant, anti-inflammatory, thrombolytic, locomotor, anxiolytic, analgesic, and antidiarrheal activities. The antioxidant activity was evaluated by DPPH scavenging assay and the total phenol and total flavonoid contents, while the anti-inflammatory activity was evaluated by a protein denaturation assay. The locomotor effects were examined using the open field test and hole-cross test. The anxiolytic effect was examined using the elevated plus maze (EPM) test, hole-board test (HBT), and light–dark test (LDT), while the analgesic activity was investigated using the acetic acid-induced writhing test. The antidiarrheal effect was evaluated by castor oil-induced diarrhea and gastrointestinal motility. Ten bioactive compounds were selected on the basis of their biological activities and further investigated using molecular docking simulation to correlate with the identified pharmacological properties. Additionally, the ADME properties of the compounds were evaluated according to their drug-likeness profile. MECP had a maximum total phenol content of 209.85 ± 3.40 gallic acid equivalents/g extract and a total flavonoid content of 105.17 ± 3.45 quercetin equivalents/g extract, with an IC value of 631.44 μg/mL. MECP (62.5–500 μg/mL) elicited 20.96–38.12% decreased protein denaturation compared to diclofenac sodium (65.40–83.50%), while a 35.72% (P < 0.001) clot lysis activity was observed for the 10 mg/mL concentration. MECP induced a dose-dependent reduction in locomotor activity, with a significant anxiolytic effect. In the analgesic test, MECP (200, 400 mg/kg) showed a 45.12% and 58.82% inhibition in analgesia, and the 400 mg/kg dose elicited a 27.5% inhibition in intestinal motility. These findings suggest that MECP might be effective in treating antioxidant, anti-inflammatory, and neuropharmacological defects, but this requires further study.
机译:当前的研究旨在定性和定量地确定甲醇提取物(MECP)的植物化学成分,以及其抗氧化剂,消炎药,血栓溶解剂,运动药,抗焦虑药,镇痛药和止泻药的活性。通过DPPH清除测定,总酚和总黄酮含量评估抗氧化活性,而通过蛋白质变性测定评估抗炎活性。使用开放视野测试和跨孔测试检查运动效果。使用高架迷宫(EPM)试验,孔板试验(HBT)和明暗试验(LDT)检查了抗焦虑作用,同时使用乙酸诱导的扭体试验研究了镇痛活性。通过蓖麻油引起的腹泻和胃肠蠕动来评估抗腹泻作用。根据其生物活性选择了十种生物活性化合物,并使用分子对接模拟进行了进一步研究,以使其与已确定的药理特性相关联。另外,根据化合物的药物相似性对其化合物的ADME性质进行了评估。 MECP的最大总酚含量为209.85±3.40没食子酸当量/ g提取物,总黄酮含量为105.17±3.45槲皮素当量/ g提取物,IC值为631.44μg/ mL。与双氯芬酸钠(65.40–83.50%)相比,MECP(62.5–500μg/ mL)引起的蛋白质变性降低了20.96–38.12%,而在10 mg / mL的浓度下,凝块裂解活性为35.72%(P <0.001)。 MECP引起运动活性的剂量依赖性降低,具有明显的抗焦虑作用。在镇痛试验中,MECP(200,400 mg / kg)表现出45.12%和58.82%的镇痛抑制作用,而400 mg / kg的剂量引起27.5%的肠蠕动抑制作用。这些发现表明,MECP可能有效治疗抗氧化剂,抗炎药和神经药理学缺陷,但这需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号